UPDATE: Feltl and Company Raises PT to $12.75 on Novadaq Technologies Post Analyst Day

Feltl and Company reiterated its Strong Buy rating on Novadaq Technologies NVDQ and increased its price target from $9.75 to $12.75. Feltl and Company commented, "We attended Novadaq's analyst day presentation yesterday. Six surgeons spoke favorably of Novadaq's imaging technology. They noted that Novadaq's technology improves upon clinical judgment and is better than any past, present, or future technology they are aware of. Panel members mentioned a key differentiating aspect to Novadaq's technology is the ability to visualize microvasculature, which they saw as unique. … We are raising our price target to $12.75 (7.0x 2014 EV/sales) from $9.75 and reiterating our STRONG BUY rating." Novadaq Technologies closed at $9.38 on Monday.